Most people who used Anktiva with or without bnAbs experienced typical viral rebound after stopping antiretrovirals, but a minority had longer remission. Studies at #AIDS2026 saw favorable changes in the viral reservoir & immune responses, suggesting it could help achieve a functional cure for HIV.
Anti-gender attacks are a health emergency for trans communities. At #AIDS2026, Pedro Ivo Oliveira, Health Officer at Global Action for Trans Equality, called for collective action to protect trans rights. Coordination, collectivity and community are key.
🌍 Community priorities are central to #IAS2027
Four civil society partners are helping drive community components, develop activities & engage networks:
🔹 @brentallankidd.bsky.social, @ASHMMedia
🔹 Luciana Kamel, INI-Fiocruz
🔹 Pank Sethi, @positiveeast.bsky.social
🔹 Florian Vock, Aids-Hilfe Schweiz
🌍 #AIDS2026 : quels enseignements pour la riposte au VIH ?
Dépendance financière, accessibilité des innovations, droits humains... L’Initiative – Expertise France revient sur ce que cette conférence révèle de l’évolution de la riposte au VIH 👉 urls.fr/xOBAdg @iasociety.bsky.social
HIV care has never been more advanced. But is everyone able to access it? Stigma, marginalisation and barriers to healthcare continue to stand in the way of health equity. At #AIDS2026, Alexandre Putti and João Netto shared key perspectives on what needs to change.
🌍 Progress in #HIV science must go hand in hand with equitable access.
In a new interview Kenneth Ngure discusses his priorities as IAS President and what it will take to ensure advances in HIV science reach the people and communities who need them.
Read the interview 👇
You can now watch our #AIDS2026 satellite, 'Children can't wait: From funding crisis to foundational fixes', on demand.
📢 Calling community organizations across Europe!
Apply for up to USD 10,000 to turn scientific evidence into community-led impact & showcase your work at #HIVR4P2027 or #IAS2027.
📅 Learn more & apply by 25 October:
📢 Call for papers! The Journal of the International AIDS Society will launch a supplement on long-acting antiretroviral regimens in conjunction with #IAS2027.
✅ Learn more & submit by 1 December 2026:
https://www.iasociety.org/sites/default/files/JIAS/JIAS_Call_for_papers_JIAS_long_acting.pdf
Includes the pre-conference: #HIV cure without borders: Science, community and Latin America and Caribbean perspectives:
plus.iasociety.org/webcasts/hiv...
plus.iasociety.org/webcasts/hiv...
plus.iasociety.org/webcasts/hiv...
💡 #AI was a major topic at #AIDS2026 – from its potential to transform the #HIV response to how we use it responsibly, effectively & equitably.
🎥 Explore sessions on AI & HIV, now free on #IASPlus:
https://plus.iasociety.org/search/resources/convening/402/type-of-content/99?query=AI&search-op=and
Thanks for checking. Everything including the e-posters are now on IAS+.
🌍 What were key takeaways from #AIDS2026?
Hear IAS President Kenneth Ngure & other leading experts unpack the latest trends, emerging priorities & critical discussions from the conference:
https://plus.iasociety.org/search/resources/content-theme/34/type-of-content/104?query=2026&search-op=and
“The future of AI in HIV should be shaped with communities, not simply built from data about them.” — Solange Baptiste, @itpc.bsky.social
The latest AI + HIV newsletter explores #AIDS2026 rx, emerging tools, governance, equity and accountability.
🔗 Read the issue: avac.org/ai-hiv-issue2/
🫰Supporting harm reduction means supporting trans equity. At #AIDS2026, Pedro Ivo Oliveira from Global Action for Trans Equality highlighted the urgent need for new, sustainable funding for these strategies.
🔬 With #HIVR4P2027 announced for #Geneva, discover what to expect from the only global conference focused exclusively on #HIV prevention research & how it will build shared momentum with #IAS2027 across the HIV science community.
https://www.iasociety.org/news-release/hivr4p-2027-take-place-geneva
📢 #HIVR4P2027 is coming to #Geneva, #Switzerland!
The IAS will host the only global conference focused exclusively on #HIV prevention research from 10–12 July 2027, immediately preceding #IAS2027 from 12–15 July.
Learn more now 👇
